Medicxi Ventures Management (Jersey) Ltd Portfolio Stock Holdings
Medicxi Ventures Management (Jersey) Ltd disclosed 4 stock positions valued at approximately $981.8 million in its latest SEC 13F filing. The largest holdings include CENTESSA PHARMACEUTICALS PLC, NEWAMSTERDAM PHARMA COMPANY, and PHATHOM PHARMACEUTICALS INC. The filing reflects positions held as of March 31, 2026 and was filed on April 21, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 4
- Portfolio Value
- $981.8M
Holdings by Sector
Medicxi Ventures Management (Jersey) Ltd Portfolio Holdings in Q1 2026
4 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | CNTA | Healthcare | 80.76% | 19,963,157 | - | - | $792,936,596 |
| NEWAMSTERDAM PHARMA COMPANY | NAMSW | Other | 8.72% | 2,674,182 | -195,383 | -6.81% | $85,600,566 |
| PHATHOM PHARMACEUTICALS INC | PHAT | Healthcare | 8.45% | 7,464,572 | - | - | $82,931,395 |
| AURA BIOSCIENCES INC | AURA | Healthcare | 2.07% | 3,039,892 | - | - | $20,336,877 |